Suggestions
David Carmel
Impatient about getting therapies to those in need
David A. Carmel is a prominent executive in the biotechnology and healthcare sectors who currently serves as the Chief Growth and Innovation Officer at the Foundation for the National Institutes of Health (FNIH).13 He joined the FNIH in September 2022 as the organization's first Chief Growth and Innovation Officer, where he is a key member of the executive leadership team.12
Career Highlights
Biotech and Healthcare Experience:: Carmel has an extensive background in the biotechnology industry. Prior to joining FNIH, he held several notable positions:
- Senior Vice President of Public Affairs and Communications at eGenesis, where he led a $125 million Series C financing round.3
- Vice President at Atara Biotherapeutics, managing collaborations with major research institutions.3
- Principal at Carmel Asset Management, where he led life science investments.3
- Vice President of Business Development at StemCyte, Inc.3
Government and Advisory Roles::
- Served as a White House Fellow from 2002 to 2003.1
- Appointed by Governor Andrew Cuomo to the New York Life Science Advisory Board.13
Education and Achievements
Carmel's educational background includes:
- Bachelor's degree, magna cum laude, from Harvard College.1
- MBA with a certificate in healthcare from Stanford Graduate School of Business.13
He is also recognized as a Henry Crown Fellow of the Aspen Institute.1
Personal Impact
An unexpected personal event significantly influenced Carmel's career path. In 1999, he sustained a spinal cord injury in a diving accident.4 This experience led him to focus on healthcare and biotechnology, driving his passion for bringing new therapies to patients.4
Current Role and Initiatives
At FNIH, Carmel leads the communications and events divisions, aiming to expand the foundation's scale and impact.1 His role involves bridging his expertise in biotechnology, business development, and public affairs to advance the mission of the FNIH in supporting biomedical research and innovation.
Highlights
I'm excited to be speaking at the Fierce Pharma PR & Communications Summit 2024. Please join for our panel on "Next-Level Partnerships" on Monday, July 8 at the Westin in Jersey City, NJ. Learn more https://lnkd.in/e8eXytMy
#FiercePharmaPR #FierceBiotech #FiercePharma #WeAreFierce #BiotechEvents #PharmaEvents Fierce Life Sciences Events
On this Lou Gehrig Day, I hope that you will watch a documentary about someone equally deserving of a national day of recognition, Brian Wallach. For Love & Life, No Ordinary Campaign https://lnkd.in/emXwxu_p tells the story of Brian and his amazing wife Sandra as they dismantle the obstacles to progress for ALS. What they figured out, and what is underappreciated, is that grassroots activism from people living with diseases and conditions can change public policy in a dramatic way. Disease does not discriminate by geography, race, religion, or political affiliation. This is one of the reasons why Brian and Sandra got transformational legislation, especially ACT for ALS, passed unanimously through Congress. You will smile at the witty repartee between Brian and Sandra. This native New Yorker also appreciates Brian's penchant for dropping an expletive at just the right comedic moment. It has been a pleasure to work with Brian in the formation of the Accelerating Medicines Partnership in ALS and seeing his leadership in action. Thank you, Brian, for your friendship and for delivering the most compelling closing argument imaginable.
